isirv is an open membership organization, run democratically, and based on the principle of an independent scientific body of individual scientists, clinicians, public health experts, and others with a professional interest in influenza and other respiratory viruses.
isirv is registered in England as a company limited by guarantee (the format for not-for-profit organisations) and is also registered with the Charity Commission (Company number 6021083, Registered charity number 1118829).
Most isirv Board Members are elected by the society's membership. One third of the elected Board positions are subject to election each year. Thus Board members normally serve terms of three years and have around four Board meetings a year. In addtion to the elected Board members, the Editor-in-Chief of the journal and the Chair of the isirv Antiviral Group (AVG) are ex-officio members and the Financial Adviser is co-opted.
The officers of isirv (Chair, Deputy Chair, Treasurer, and Secretary) are elected by the Board. They tend to meet at least once a quarter in between Board meetings. There is also a Finance Group comprising the Officers plus Honorary Financial Adviser and the Chair of AVG which meets as necessary.
Since 2010 there has been provision in isirv's statutes for the creation of Special Interest Groups (SIGs) through which interested members can pursue activities of a more specialist nature. The first such body is the Antiviral Group which was previously a separate organisation, the Neuraminidase Inhibitor Susceptibility Network (NISN).
It is hoped that members will soon come forward with ideas for additional SIGs.
isirv’s activities are funded by annual subscriptions (membership), surpluses from scientific meetings including Options, and royalties from the journal.